These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37457712)

  • 1. Downregulation of monocyte miRNAs: implications for immune dysfunction and disease severity in drug-resistant tuberculosis.
    Sampath P; Moorthy M; Menon A; Madhav L; Janaki A; Dhanapal M; Natarajan AP; Hissar S; Ranganathan UD; Ramaswamy G; Bethunaickan R
    Front Immunol; 2023; 14():1197805. PubMed ID: 37457712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Frequencies of Intermediate Monocyte Subsets Among Individuals Infected With Drug-Sensitive or Drug-Resistant
    Sampath P; Natarajan AP; Moideen K; Kathamuthu GR; Hissar S; Dhanapal M; Jayabal L; Ramesh PM; Tripathy SP; Ranganathan UD; Babu S; Bethunaickan R
    Front Immunol; 2022; 13():892701. PubMed ID: 35911760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood monocyte and dendritic cell profiles among people living with HIV with Mycobacterium tuberculosis co-infection.
    Rambaran S; Maseko TG; Lewis L; Hassan-Moosa R; Archary D; Ngcapu S; Garrett N; McKinnon LR; Padayatchi N; Naidoo K; Sivro A
    BMC Immunol; 2023 Jul; 24(1):21. PubMed ID: 37480005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug-resistant tuberculosis patients expressing the HLA-DRB1*04 allele, and after treatment they show a low frequency of HLA-II+ monocytes and a chronic systemic inflammation.
    Ocaña-Guzman R; Tellez-Navarrete NA; Preciado-Garcia M; Ponce-Gallegos MA; Buendia-Roldan I; Falfán-Valencia R; Chavez-Galan L
    Microb Pathog; 2021 Apr; 153():104793. PubMed ID: 33582220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi) /CD16(neg) monocytes: Expansion of CD14(hi) /CD16(pos) and contraction of CD14(lo) /CD16(pos) monocytes in acute liver failure.
    Abeles RD; McPhail MJ; Sowter D; Antoniades CG; Vergis N; Vijay GK; Xystrakis E; Khamri W; Shawcross DL; Ma Y; Wendon JA; Vergani D
    Cytometry A; 2012 Oct; 81(10):823-34. PubMed ID: 22837127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection.
    de Araujo LS; Ribeiro-Alves M; Leal-Calvo T; Leung J; Durán V; Samir M; Talbot S; Tallam A; Mello FCQ; Geffers R; Saad MHF; Pessler F
    mBio; 2019 Dec; 10(6):. PubMed ID: 31796535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Dual Marker for Monitoring MDR-TB Treatment: Host-Derived miRNAs and
    Carranza C; Herrera MT; Guzmán-Beltrán S; Salgado-Cantú MG; Salido-Guadarrama I; Santiago E; Chávez-Galán L; Gutiérrez-González LH; González Y
    Front Immunol; 2021; 12():760468. PubMed ID: 34804048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated bioinformatics analysis and validation revealed potential immune-regulatory miR-892b, miR-199b-5p and miR-582-5p as diagnostic biomarkers in active tuberculosis.
    Zhang Y; Zhang X; Zhao Z; Zheng Y; Xiao Z; Li F
    Microb Pathog; 2019 Sep; 134():103563. PubMed ID: 31175974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and -resistant tuberculosis: however, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long time.
    Téllez-Navarrete NA; Ramon-Luing LA; Muñoz-Torrico M; Preciado-García M; Medina-Quero K; Hernandez-Pando R; Chavez-Galan L
    Mol Med; 2021 Jul; 27(1):76. PubMed ID: 34261449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Immunological changes in patients with distinct clinical outcomes during Mycobacterium tuberculosis infection.
    Morais-Papini TF; Coelho-Dos-Reis JGA; Wendling APB; do Vale Antonelli LR; Wowk PF; Bonato VLD; Augusto VM; Elói-Santos S; Martins-Filho OA; Carneiro CM; Teixeira-Carvalho A
    Immunobiology; 2017 Nov; 222(11):1014-1024. PubMed ID: 28619539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of latent tuberculosis infection-related microRNAs in human U937 macrophages expressing Mycobacterium tuberculosis Hsp16.3.
    Meng QL; Liu F; Yang XY; Liu XM; Zhang X; Zhang C; Zhang ZD
    BMC Microbiol; 2014 Feb; 14():37. PubMed ID: 24521422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte and Macrophage miRNA: Potent Biomarker and Target for Host-Directed Therapy for Tuberculosis.
    Sampath P; Periyasamy KM; Ranganathan UD; Bethunaickan R
    Front Immunol; 2021; 12():667206. PubMed ID: 34248945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte subset distribution and surface expression of HLA-DR and CD14 in patients after cardiopulmonary resuscitation.
    Asmussen A; Busch HJ; Helbing T; Bemtgen X; Smolka C; Bode C; Fink K; Grundmann S
    Sci Rep; 2021 Jun; 11(1):12403. PubMed ID: 34117334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of unique key genes and miRNAs in latent tuberculosis infection by network analysis.
    Lin Y; Zhang Y; Yu H; Tian R; Wang G; Li F
    Mol Immunol; 2019 Aug; 112():103-114. PubMed ID: 31082644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and phenotypic changes in monocytes from patients with tuberculosis are reversed with treatment.
    Sánchez MD; García Y; Montes C; París SC; Rojas M; Barrera LF; Arias MA; García LF
    Microbes Infect; 2006 Aug; 8(9-10):2492-500. PubMed ID: 16872859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte-related gene biomarkers for latent and active tuberculosis.
    Li Y; Deng Y; He J
    Bioengineered; 2021 Dec; 12(2):10799-10811. PubMed ID: 34751089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine upsurge among drug-resistant tuberculosis endorse the signatures of hyper inflammation and disease severity.
    Sampath P; Rajamanickam A; Thiruvengadam K; Natarajan AP; Hissar S; Dhanapal M; Thangavelu B; Jayabal L; Ramesh PM; Ranganathan UD; Babu S; Bethunaickan R
    Sci Rep; 2023 Jan; 13(1):785. PubMed ID: 36646786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a novel panel of plasma microRNAs that discriminates between Mycobacterium tuberculosis infection and healthy individuals.
    Cui JY; Liang HW; Pan XL; Li D; Jiao N; Liu YH; Fu J; He XY; Sun GX; Zhang CL; Zhao CH; Li DH; Dai EY; Zen K; Zhang FM; Zhang CY; Chen X; Ling H
    PLoS One; 2017; 12(9):e0184113. PubMed ID: 28910318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte activation in persons living with HIV and tuberculosis coinfection.
    Huaman MA; Juchnowski SM; Zidar DA; Kityo CM; Nalukwago S; Nazzinda R; Fichtenbaum CJ; Longenecker CT
    AIDS; 2021 Mar; 35(3):447-452. PubMed ID: 33252496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of Circulating CD4
    Ferrian S; Ross M; Conradie F; Vally Omar S; Ismail N; Little F; Kaplan G; Fallows D; Gray CM
    Front Immunol; 2018; 9():2438. PubMed ID: 30410488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.